Each year, our crop of Fierce 15 honorees includes an increasing number of nontraditional device players. From Glooko and Propeller Health—both digital disease management platforms—to image analysis players Arterys and Zebra Medical, the way we think about medical technology and devices has changed considerably.
So much so that the FDA rolled out a new program this summer aimed at creating a new regulatory pathway to accommodate digital health software that poses a lower risk than traditional medical devices.
“FDA’s traditional approach to medical devices is not well suited to these [digital health products]. We need to make sure our approach to innovative products with continual updates and upgrades is efficient and that it fosters, not impedes, innovation,” said FDA Commissioner Scott Gottlieb at the time.
In a nod to the rise of new medical technologies, FierceMedicalDevices became FierceMedTech earlier this year. Now, we are selecting our first medtech Fierce 15—and we need your help. We are looking for medtech pioneers at the cutting edge of their field, adapting current technology, or creating entirely new systems to treat disease.
Know a medtech startup transforming the way a disease is diagnosed or treated? Let us know in the nomination form below. Check out last year’s honorees to see the type of companies we're looking for. Nominations close on Oct. 16.
The nominees should meet the following criteria:
- Companies must be privately held, not publicly traded.
- Companies should be working on treatments for human diseases.
- Executives must be available for interviews and agree to keep their status in our selection process confidential until the final list is announced.